Abstract
Sjögren’s syndrome (SS) is a common, chronic autoimmune disorder with strong female preponderance. It affects primarily the lacrimal and salivary glands, but systemic manifestations as well as lymphoma development can occur in these patients. The disease can be present alone (primary SS) or in association with the majority of the autoimmune disorders (secondary SS).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Harley JB (1987) In: Talai N, Moutsopoulos HM & Kassan SS (Eds) Sjögren’s Syndrome, pp. 218–234. Springer-Verlag, Berlin
Clark G, Reichlin M & Tomasi T (1969) J Immunol 102: 117–122
Mattioli M & Reichlin M (1974) Arthritis Rheumatism 17: 421–429
Alspaugh MA & Tan EM (1975) J Clin Invest 55: 1067–1073
Akizuki M, Powers R & Holman HR (1977) J Clin Invest 59: 796–798
Alspaugh M & Maddison PJ (1979) Arthritis Rheum 22: 796–798
Maddison P, Skinner RP, Vlachoyiannopoulos P, Breunaud BM & Hough D (1985) Clin Exp Immunol 62: 337–345
Hendrick JP, Wolin SL, Rinke J, Lerner MR & Steitz JA (1981) Mol Cell Biol 1: 1138–1149
Forman MS, Nakamura M, Mimori T, Gelpi C & Hardin JA (1985) Arthritis Rheum 28: 1350–1363
Manoussakis MN, Kistis KG, Liu X, Aidinis V, Guialis A & Moutsopoulos HM (1993) Br J Rheumatol 32: 449–455
Meilof JF, Bantjes I, De Jong J, Van Dam AP & Smeenk RJT (1990) J Immunol Meth 133: 215–226
Charles PJ, Van Venrooij WJ & Maini RN (1992) Clin Exp Rheumatol 10: 507–511
Manoussakis MN, Tzioufas AG, Pange PJE & Moutsopoulos HM (1986) Scand J Rheumatol (Suppl) 61: 89–92
Harley JB, Alexander EL, Bias NB et al. (1986) Arthritis Rheum 29: 196–206
Ben-Chetrit E, Fox RI & Tan EM (1990) Arthritis Rheum 33: 349–355
Slobbe RL, Pruijn GJM, Damen WGM, Van Der Kemp JWCM & Van Venrooij WJ (1991) Clin Exp Immunol 86: 99–105
Tarpley TM, Anderson LG & White CL (1974) Oral Surg 37: 64–74
Molina R, Provost TT & Alexander EL (1985) Arthritis Rheum 28: 1251–58
Vitali C, Bombardieri S, Moutsopoulos HM et al. (1993) Arthritis Rheum 36: 340–348
Hochberg MC, Boyd RE, Ahearn TM et al. (1985) Medicine (Baltimore) 64: 285–295
Sontheimer RD, Maddison PJ, Reichein M et al. (1982) Ann Int Med 97: 664–671
Andonopoulos AP, Skopouli FN, Dimou GS, Drosos AA & Moutsopoulos HM (1990) J Rheumatol 17: 201–204
Moutsopoulos HM, Giotaki HJ, Maddison PS, Mavridis AC, Drosos AA & Skopouli FN (1984) Ann Rheum Dis 43: 285–287
Vlachoyiannopoulos PG, Zerva LV, Skopouli FN, Drosos AA & Moutsopoulos HM (1991) J Rheumatol 18: 44–49
Laxer RM, Roberts EA, Gross KR et al. (1990) J Pediatr 116: 238–242
Watson R, Kang JE, May M, Huda KM, Kickler T & Provost TT (1988) Arch Dermatol 124: 560–563
Scott JS, Maddison PJ, Taylor RV, Esscher E, Scott O & Skinner RP (1983) N Engl J Med 309: 209–212
Waltuck J & Buyon JP (1994) Ann Int Med 120: 544–551
Bodeutsch C, De Wilde PCM, Kater L et al. (1992) Arthritis Rheum 35: 1075–1087
Moutsopoulos HM, Klippel JH, Pavlidis N et al. (1980) Arthritis Rheum 23: 36–40
Alexander EL, Arnett FC, Provost TT & Stevens MB (1983) Ann Int Med 98: 155–160
Harley JB. Alexander EL, Bias WB et al. (1986) Arthritis Rheum 29: 196–206
Harley JB (1987) In: Talai N, Moutsopoulos HM & Kassan S (Eds) Sjögren’s Syndrome. Clinical and Immunological Aspects, pp. 218–234. Springer-Verlag. Berlin
Moutsopoulos HM, Mann DL, Johnson AH & Chused TM (1979): N Engl J Med 301: 761–763
Papasteriades CA, Skopouli FN, Drosos AA, Andonopoulos AP & Moutsopoulos HM (1988) J Autoimmunity 1: 85–90
Wilson RN, Provost TT, Bias WB et al. (1984) Arthritis Rheum 27: 1245–1253
Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB & Provost TT (1986) Science 232: 1145–1147
Hamilton RG, Harley JB, Bias WB et al. (1988) Arthritis Rheum 31: 496–508
Arnett FC (1991) In: Talai N (Ed) Molecular Autoimmunity, pp. 33–46. Academic press, New York
Fujisaku A, Frank MB, Neas B, Reichlin M & Harley JB (1990) J Clin Invest 86: 606–611
Roitberg-Tambur A, Friedmann A, Safirman C et al. (1993) Human Immunol 36: 235–242
Reveille JD, Mateod MJ, Whirrington K & Arnett FC (1991) J Immunol 146: 3871–3875
Whittingham S, Mackay IR & Tait BD (1983) Aust NZ J Med 23: 565–570
Harley JB, Sestak AL, Willis LG et al. (1989) Arthritis Rheum 32: 826–836
Bell DA & Maddison PJ (1980) Arthritis Rheum 23: 1268–1273
Slobbe RL, Pruijn GJM & Van Venrooij WJ (1991) Ann Med Interne 142: 592–600
Baboonian C, Venables PJW, Booth J, Williams DG, Roffe LM & Maini RN (1989) Clin Exp Immunol 78: 454–459
Bodeutsch C, De Wilde P, Van den Hoogen F & Van Venrooij W (1992) Clin Rheumatol 11: 122
Yannopoulos DI, Roncin S, Lamour A, Pennec YL, Moutsopoulos HM & Youinou P (1992) J Clin Immunol 12: 259–265
Moutsopoulos HM (1993) Lupus 2: 209–211
Penner E and Reichlin M (1982) Arthritis Rheum 22: 1250–1253
Maddison PJ and Reichlin M (1979) Arthritis Rheum 22: 858–863
Karsh J, Harley JB, Coldstein R & Lazarovits AI (1993) Clin Exp Immunol 91: 103–109
Herreman G & Galezewski N (1985) N Engl J Med 312: 1329
Horsfall AC, Venables PJW, Taylor PW & Maini RN (1991) J Autoimmunity 4: 165–176
Alexander EL, Buyon JP, Provost TT & Guarnieri T (1992) Arthritis Rheum 35: 176–189
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Tzioufas, A.G., Moutsopoulos, H.M. (1996). Clinical significance of autoantibodies to Ro/SSA and La/SSB. In: van Venrooij, W.J., Maini, R.N. (eds) Manual of Biological Markers of Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1670-1_44
Download citation
DOI: https://doi.org/10.1007/978-94-011-1670-1_44
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-2219-1
Online ISBN: 978-94-011-1670-1
eBook Packages: Springer Book Archive